Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
A Standard patent application filed on 21 March 1995 credited to Melief, Cornelis J. M ; Visseren, M. W ; Boon-Falleur, Thierry ; Van Der Bruggen, Pierre ; Kast, W. M

Details

Application number :

21893  

Application type :

Standard  

Application status :

SEALED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof  

Inventor :

Melief, Cornelis J. M ; Visseren, M. W ; Boon-Falleur, Thierry ; Van Der Bruggen, Pierre ; Kast, W. M  

Agent name :

Griffith Hack  

Address for service :

GPO Box 1285 MELBOURNE VIC 3001  

Filing date :

21 March 1995  

Associated companies :

 

Applicant name :

Ludwig Institute for Cancer Research  

Applicant address :

1345 Avenue Of The Americas New York New York 10105 United States Of America  

Old name :

 

Original Source :

Go  

Same Inventor

• Isolated peptides derived from mage tumor rejection antigen...